双等位基因HFM1变异通过不同程度损害交叉形成导致人类非梗阻性无精子症伴减数分裂停滞
研究在一个巴基斯坦近亲婚配家系的两名不育兄弟和三名无关中国非梗阻性无精子症(NOA)男性中筛查HFM1变异,鉴定出6个纯合或复合杂合变异,患者睾丸组织学显示减数分裂中期I(MMI)停滞,小鼠模型重现了减数分裂缺陷并证实变异致病性。
要点
- 双等位基因HFM1变异导致人类NOA伴交叉形成受损和MMI停滞。
- 患者睾丸组织学显示精子发生停滞于MMI。
- 小鼠模型重现患者减数分裂缺陷,证实变异致病性。
核心结论
- 双等位基因HFM1变异导致人类男性不育,表现为非梗阻性无精子症(NOA)伴交叉形成受损和减数分裂中期I(MMI)停滞。
- HFM1可能以剂量依赖方式调控减数分裂交叉形成。
研究设计与样本
- 招募一个巴基斯坦近亲婚配家系(两名不育兄弟)和三名无关中国NOA男性进行致病变异筛查。
- 所有患者诊断为特发性NOA,中国患者经睾丸组织学分析和/或免疫荧光染色确认减数分裂缺陷。
- 进行外显子组测序和生物信息学分析筛选候选致病变异。
- 在小鼠中构建等效突变进行体内致病性评估。
主要发现
- 在三名中国NOA患者和巴基斯坦家系两名NOA兄弟中鉴定出HFM1的6个纯合或复合杂合变异。
- 携带变异患者的睾丸组织学分析显示精子发生停滞于MMI。
- 模拟患者HFM1变异的小鼠重现了患者的减数分裂缺陷,证实所鉴定变异的致病性。
- Hfm1变异导致染色体轴上HFM1焦点不同程度减少,并在突变雄鼠中造成不同程度的联会和交叉形成缺陷。
- Hfm1突变雌鼠表现为不育或生育力低下,卵子发生受到不同程度影响。
临床怎么用
- 作者认为HFM1变异可损害精子发生和卵子发生且严重程度不一,并可能与男性产生少量精子和女性生育力低下相容,扩展了HFM1变异患者的表型谱。
局限性
- 本研究的一个局限性是样本量小。
- 由于无法获得新鲜睾丸样本,未能在患者精母细胞中检测联会和交叉形成缺陷。
- 由于缺乏抗体,无法量化这些变异对HFM1蛋白水平的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do variants in helicase for meiosis 1 (HFM1) account for male infertility in humans? SUMMARY ANSWER: Biallelic variants in HFM1 cause human male infertility owing to non-obstructive azoospermia (NOA) with impaired crossover formation and meiotic metaphase I (MMI) arrest. WHAT IS KNOWN ALREADY: HFM1 encodes an evolutionarily conserved DNA helicase that is essential for crossover formation and completion of meiosis. The null mutants of Hfm1 or its ortholog in multiple organisms displayed spermatogenic arrest at the MMI owing to deficiencies in synapsis and severe defects in crossover formation. Although HFM1 variants were found in infertile men with azoospermia or oligozoospermia, the causal relationship has not yet been established with functional evidence. STUDY DESIGN, SIZE, DURATION: A Pakistani family, having two infertile brothers born to consanguineous parents, and three unrelated Chinese men diagnosed with NOA were recruited for pathogenic variants screening. PARTICIPANTS/MATERIALS, SETTING, METHODS: All the patients were diagnosed with idiopathic NOA and, for the Chinese patients, meiotic defects were confirmed by histological analyses and/or immunofluorescence staining on testicular sections. Exome sequencing and subsequent bioinformatic analyses were performed to screen for candidate pathogenic variants. The pathogenicity of identified variants was assessed and studied in vivo in mice carrying the equivalent mutations. MAIN RESULTS AND THE ROLE OF CHANCE: Six variants (homozygous or compound heterozygous) in HFM1 were identified in the three Chinese patients with NOA and two brothers with NOA from the Pakistani family. Testicular histological analysis revealed that spermatogenesis is arrested at MMI in patients carrying the variants. Mice modeling the HFM1 variants identified in patients recapitulated the meiotic defects of patients, confirming the pathogenicity of the identified variants. These Hfm1 variants led to various reductions of HFM1 foci on chromosome axes and resulted in varying degrees of synapsis and crossover formation defects in the mutant male mice. In addition, Hfm1 mutant female mice displayed infertility or subfertility with oogenesis variously affected. LIMITATIONS, REASONS FOR CAUTION: A limitation of the current study is the small sample size. Owing to the unavailability of fresh testicular samples, the defects of synapsis and crossover formation could not be detected in spermatocytes of patients. Owing to the unavailability of antibodies, we could not quantify the impact of these variants on HFM1 protein levels. WIDER IMPLICATIONS OF THE FINDINGS: Our findings provide direct clinical and in vivo functional evidence that HFM1 variants cause male infertility in humans and also suggest that HFM1 may regulate meiotic crossover formation in a dose-dependent manner. Noticeably, our findings from mouse models showed that HFM1 variants could impair spermatogenesis and oogenesis with a varying degree of severity and might also be compatible with the production of a few spermatozoa in men and subfertility in women, extending the phenotypic spectrum of patients with HFM1 variants. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (31890780, 32070850, 32061143006, 32000587 and 31900398) and the Fundamental Research Funds for the Central Universities (YD2070002007 and YD2070002012). The authors declare no potential conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Xie X, Murtaza G, Li Y, et al. Biallelic HFM1 variants cause non-obstructive azoospermia with meiotic arrest in humans by impairing crossover formation to varying degrees. Hum Reprod. 2022. PMID: 35526155. doi:10.1093/humrep/deac092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。